Middle-down Analysis of Monoclonal Antibody Middle using Nano-flow Liquid Chromatography and a Novel Tribrid Orbitrap Mass Spectrometer

Importance of the Topic

Monoclonal antibodies are key biotherapeutics with complex structures and labile modifications. Middle-down mass spectrometry enables analysis of large protein fragments, bridging top-down and bottom-up approaches to deliver detailed sequence information and precise localization of posttranslational modifications such as glycosylation and terminal clipping.

Study Objectives and Overview

This work presents a sensitive middle-down method for comprehensive characterization of a monoclonal antibody. The goals include accurate intact mass measurement, isotopic resolution of subunits, and complementary fragmentation to maximize sequence coverage and confidently assign glycosylation sites and other modifications.

Methodology

• Sample Preparation: The antibody was cleaved at the hinge with recombinant IdeS enzyme and reduced to generate Fd, Fc/2, and light chain subunits.
• Liquid Chromatography: Subunits were separated by nano-flow reversed-phase chromatography on a 200 μm×25 cm monolithic column using an 800 nL/min gradient from 5% to 60% acetonitrile with 0.1% formic acid over 32 minutes.
• Data Analysis: Full mass spectra were deconvoluted for mass determination, and tandem spectra were processed with dedicated software for middle-down proteoform mapping.

Instrumentation

• Thermo Scientific Orbitrap Fusion Tribrid Mass Spectrometer
• Thermo Scientific EASY-nLC 1000 nano-LC system
• Thermo Scientific PepSwift Monolithic Nano Column (200 μm×25 cm)
• Software: Protein Deconvolution 3.0, Xtract, ProSightPC 3.0

Main Results and Discussion

The intact antibody was measured with high mass accuracy within a few ppm of theoretical values. Subunit spectra provided baseline isotopic resolution with monoisotopic mass errors below 2.2 ppm. Combined HCD and ETD fragmentation of Fd, Fc/2, and light chain achieved approximately 50% sequence coverage on average. ETD preserved labile modifications and localized a core fucosylated glycan (G0F) at Asn61 on the Fc/2 domain, supported by specific fragment ions. The method also identified N-terminal pyroglutamate formation and C-terminal lysine clipping.

Practical Benefits and Applications

• Rapid, reliable subunit-level structural characterization of monoclonal antibodies
• Unambiguous mapping of glycosylation sites and detection of other critical modifications
• Valuable for biopharmaceutical quality control, biosimilar comparability, and epitope mapping

Future Trends and Opportunities

Emerging developments may include incorporation of ultraviolet photodissociation, automated high-throughput sample handling, and AI-driven data analysis to deepen proteoform profiling. These advances will further accelerate and refine monoclonal antibody characterization in both research and manufacturing contexts.

Conclusion

The developed middle-down approach, combining nano-flow LC, high-resolution Orbitrap analysis, and complementary fragmentation, provides detailed subunit and proteoform insights for monoclonal antibodies. It delivers robust sequence coverage and precise PTM localization, establishing a powerful platform for advanced antibody characterization in biopharmaceutical applications.